- Home
- BCRX vs AVPT Comparison
BCRX vs AVPT Comparison
Compare BCRX & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | AVPT |
|---|---|---|
| Founded | 1986 | 2001 |
| Country | United States | United States |
| Employees | N/A | 3443 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | AVPT |
|---|---|---|
| Price | $9.01 | $9.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $20.82 | $16.64 |
| AVG Volume (30 Days) | ★ 3.9M | 1.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $25.00 |
| Revenue Next Year | $12.55 | $19.63 |
| P/E Ratio | ★ $7.34 | $1,348.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $8.84 |
| 52 Week High | $11.31 | $20.25 |
Technical Indicators
Market Signals| Indicator | BCRX | AVPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 49.19 |
| Support Level | $8.73 | $9.86 |
| Resistance Level | $9.14 | $10.40 |
| Average True Range (ATR) | 0.36 | 0.33 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 32.68 | 68.49 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About AVPT AvePoint Inc.
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.